1/30
Flashcards covering vertebral anatomy, lead implantation procedures, clinical study outcomes (B-Study, RESTORE), and patient identification for restorative neurostimulation.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
What nerve is the primary target of stimulation by ReActiv8?
The medial branch of the dorsal ramus of L2
According to the Guven et al study, what was the primary aim regarding lumbar medial branch radiofrequency neurotomy (RFN)?
To assess the asymmetry in muscle morphology changes in patients undergoing unilateral RFN
How is the twelfth thoracic vertebra (T12) identified as a landmark?
It is the lowest of two vertebrae with floating ribs (ribs that do not attach to the sternum)
What is the primary mechanism of the Intracept procedure?
It ablates the basivertebral nerve to cut off endplate pain signals
What specific feature of the basivertebral nerve contributes to the durability of the Intracept procedure?
It is not myelinated and does not tend to grow back
What core problem does ReActiv8 address that Intracept does not?
Segmental instability due to poor multifidus control
For a standard ReActiv8 implant, what is the required lead and spare count?
2 leads per implant plus 2 spares
Why is traceability for Class III devices considered a core requirement?
It allows identification of every implanted component and affected patient if safety or labeling changes
When should the initial IPG set up programming occur for an implant?
Before the patient is on the table
What is the positioning goal for reducing difficulty with imaging and needle placement?
Neutral, flatter lumbar lordosis
What are the five salient keys to a successful ReActiv8 procedure?
Fluoroscopy alignment, fascial entry point, final delivery needle position, depth of lead placement, and strain relief loop
During lead fixation, how many times should the light tug test be performed?
3 to 4 times
What actions are explicitly included in final confirmation testing at case completion?
2Hz twitch test and electrode impedance measurements
What is considered the 'normal' impedance range in the implant and programming manual?
150 to 4999Ohms
At what level should stimulation typically begin for intra-operative twitch testing?
1.0mA
According to the Ardeshiri et al. 'Older Patient' study, what percentage of the oldest quartile experienced a 50% reduction in pain after two years?
62%
In the Hodges et al. 'Sheep Study', which area of the multifidus showed the greatest reduction in fibrotic changes?
Stimulated muscle fascicles at L4
What indicator was used in the Hodges et al. study to analyze fibrosis in the multifidus?
Collagen-I and Collagen-III levels
Which three subsystems are involved in spinal stability?
Muscles (active), brain (neural), and spine (passive)
In Phase I of Patient Identification, what criteria combine with Axial Back Pain to indicate Multifidus Dysfunction?
MRI Biomarker (Grade 2 and 3)
What are the three dysfunctional movement patterns identified in Phase II of Patient Identification?
Instability or Weakness, Flexion with Light Load, and Positional Transitions
Where is the midline incision placed during a ReActiv8 implant?
From the identified AP fascial entry point extending caudal approximately 3−4cm
What percentage of patients in the ReActiv8-B Study became 'remitters' (VAS≤2.5cm) at five years?
67%
What is the ICD-10 code for 'Dysfunction of the multifidus muscles, lumbar region'?
M62.85
What was the primary endpoint of the RESTORE Trial?
Disability measured by ODI
In the ReActiv8-B Study at five years, what was the observed improvement in the Visual Analog Scale (VAS)?
7.3 to 2.4cm
What was the average duration of back pain history for subjects in the RESTORE study?
19 years
What percentage of patients who used opioids at baseline in the ReActiv8-B study eliminated or reduced their use at five years?
69%
Which radiographic scan type is commonly used to identify fatty infiltration in the Multifidus?
MRI
What are the documented components of the comprehensive ReActiv8 clinical evidence body?
5 years of follow-up, 5 separate clinical studies, 567 total patients, and 1800 years of follow-up